Am. J. Respir. Crit. Care Med., Volume 156, Number 1, July 1997, 94-100

Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage

MASSIMO TRIGGIANI, VALERIA DE MARINO, MATTEO SOFIA, STANISLAO FARAONE, GIUSEPPE AMBROSIO, LUIGI CARRATÙ, and GIANNI MARONE

Division of Clinical Immunology and Allergy and Division of Respiratory Diseases, University of Naples Federico II; and Division of Cardiology, University of Perugia, Italy

Platelet-activating factor (PAF) is a mediator produced in human airways during acute and chronic inflammatory lung diseases. The levels of PAF are regulated by acetylhydrolase (AH), the enzyme that converts PAF to lyso-PAF. To determine whether AH was present in human bronchoalveolar lavage (BAL) fluid, BAL was obtained from normal donors (n = 18) and from adult patients with mild bronchial asthma (n = 15) or with lung fibrosis (n = 15). AH activity was consistently found in the cell-free BAL fluid. BAL-AH is an enzyme different from secretory phospholipase A₂ and from plasma AH and erythrocyte AH. Furthermore, BAL-AH is inhibited as much as 95% by exposure to an oxygen radical-generating system (xanthine/xanthine oxidase). BAL-AH is significantly correlated with the number of BAL macrophages (r_s = 0.63; p < 0.02). In addition, BAL macrophages release AH both spontaneously and after stimulation with tumor necrosis factor-alpha (TNF-) (100 ng/ml). BAL-AH activity in patients with bronchial asthma (1.32 ± 0.18 pmol of PAF converted to lyso-PAF/min) is significantly lower than that in normal donors (2.25 ± 0.26 pmol/min; p < 0.001). In contrast, BAL-AH activity in patients with lung fibrosis (6.13 ± 0.81 pmol/min) is higher than that found in normal donors (p < 0.01). The variations in BAL-AH activity in patients with bronchial asthma or lung fibrosis are due to a reduction and to an increase, respectively, in the number of active molecules rather than to changes in enzyme affinity. These data demonstrate that human BAL fluid contains an extracellular AH activity that inactivates PAF released in the airways. BAL-AH is secreted by alveolar macrophages and is highly sensitive to oxygen radical-induced damage. The secretion and inactivation of BAL-AH may influence the levels of this enzyme in BAL fluid during acute and chronic inflammatory lung diseases and, ultimately, regulate the proinflammatory activities of PAF in these disorders.

This article has been cited by other articles:

				B. P. Hurley and B. A. McCormick Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation Infect. Immun., June 1, 2008; 76(6): 2259 - 2272. [Full Text] [PDF]

				C. Iribarren, M. D. Gross, J. A. Darbinian, D. R. Jacobs Jr, S. Sidney, and C. M. Loria Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity With Calcified Coronary Plaque in Young Adults: The CARDIA Study Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 216 - 221. [Abstract] [Full Text] [PDF]

				J. Lindbom, A.G. Ljungman, M. Lindahl, and C. Tagesson Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa Eur. Respir. J., July 1, 2001; 18(1): 130 - 138. [Abstract] [Full Text] [PDF]

				J. D. Kim, C. J. Baker, R. F. Roberts, S. H. Darbinian, K. A. Marcus, S. M. Quardt, V. A. Starnes, and M. L. Barr Platelet activating factor acetylhydrolase decreases lung reperfusion injury Ann. Thorac. Surg., August 1, 2000; 70(2): 423 - 428. [Abstract] [Full Text] [PDF]

				M. Triggiani, F. Granata, A. Oriente, V. De Marino, M. Gentile, C. Calabrese, C. Palumbo, and G. Marone Secretory Phospholipases A2 Induce {beta}-Glucuronidase Release and IL-6 Production from Human Lung Macrophages J. Immunol., May 1, 2000; 164(9): 4908 - 4915. [Abstract] [Full Text] [PDF]

				E. I. Kitsiouli, G. Nakos, and M. E. Lekka Differential determination of phospholipase A2 and PAF-acetylhydrolase in biological fluids using fluorescent substrates J. Lipid Res., December 1, 1999; 40(12): 2346 - 2356. [Abstract] [Full Text] [PDF]

				N. SATOH, K. ASANO, K. NAOKI, K. FUKUNAGA, M. IWATA, M. KANAZAWA, and K. YAMAGUCHI Plasma Platelet-activating Factor Acetylhydrolase Deficiency in Japanese Patients with Asthma Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 974 - 979. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				Y.-P. LOU, K. TAKEYAMA, K. M. GRATTAN, J. A. LAUSIER, I. F. UEKI, C. AGUSTI, and J. A. NADEL Platelet-activating Factor Induces Goblet Cell Hyperplasia and Mucin Gene Expression in Airways Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1927 - 1934. [Abstract] [Full Text] [PDF]